KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $65.50 $80.00 Friday, 26th Apr 2024 AXSM stock ended at $71.71. This is 0.266% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $69.70 to a day high of $72.43.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Aug 19, 2021 $19.90 $20.56 $19.38 $19.91 1 407 909
Aug 18, 2021 $21.06 $21.33 $20.11 $20.30 1 250 713
Aug 17, 2021 $20.97 $21.41 $20.50 $21.02 1 562 534
Aug 16, 2021 $22.79 $22.86 $21.10 $21.22 1 783 694
Aug 13, 2021 $24.04 $24.50 $22.29 $22.86 1 526 711
Aug 12, 2021 $23.98 $24.68 $22.88 $24.31 1 651 593
Aug 11, 2021 $24.19 $25.60 $23.55 $23.93 3 107 055
Aug 10, 2021 $26.25 $26.37 $23.04 $23.78 6 520 254
Aug 09, 2021 $33.00 $35.00 $27.30 $27.37 10 840 625
Aug 06, 2021 $50.67 $51.16 $49.28 $51.16 358 007
Aug 05, 2021 $50.20 $51.34 $48.92 $50.66 276 857
Aug 04, 2021 $49.19 $51.31 $48.86 $49.35 315 988
Aug 03, 2021 $50.88 $51.37 $48.64 $49.18 326 432
Aug 02, 2021 $49.27 $51.58 $48.97 $50.32 374 320
Jul 30, 2021 $50.49 $50.49 $48.34 $48.59 487 367
Jul 29, 2021 $52.95 $54.30 $50.35 $50.57 326 218
Jul 28, 2021 $52.71 $53.86 $52.28 $52.81 189 557
Jul 27, 2021 $51.38 $53.21 $50.25 $52.66 391 841
Jul 26, 2021 $53.63 $54.09 $50.93 $51.79 342 426
Jul 23, 2021 $55.96 $56.04 $53.55 $53.68 269 872
Jul 22, 2021 $57.30 $58.21 $55.86 $55.88 246 037
Jul 21, 2021 $55.36 $57.58 $55.15 $57.11 338 279
Jul 20, 2021 $56.09 $56.77 $54.72 $55.36 393 544
Jul 19, 2021 $53.57 $56.70 $53.16 $56.09 457 285
Jul 16, 2021 $56.95 $56.95 $53.82 $54.22 518 598
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT